I have spent decades as a health-care executive and pediatric surgeon. I am often asked to reflect on the biggest advancements that have been developed to save children’s lives.
While I can acknowledge that there are many technologies available to surgeons today that did not exist when I first began operating, I can’t ignore the fact that innovation in medical devices and technology for children continues to occur much more slowly than it does for adults.
Image: https://thehill.com
It’s the first expansion outside of the U.S. for the Loudoun company.
Image: Crystal Icenhour is the CEO of Aperiomics in Sterling. Credit – JOANNE S. LAWTON
After a long suspenseful day, University of Maryland, Baltimore County earned the top spot as national winner of the U.S. Department of Energy’s CyberForce Competition.
The U.S. Department of Energy (DOE) announced University of Maryland, Baltimore County as the national winner of DOE’s fifth CyberForce Competition™, held on November 16, 2019 at 10 of the national laboratories across America. The competition challenged 105 collegiate teams to build simulated energy infrastructure and defend it from cyberattacks. Regional first place winners were recognized by each participating laboratory.
Image: CAPTION The team from University of Maryland, Baltimore County won the national DOE CyberForce Competition over the weekend, besting more than 100 teams from 10 national laboratories across the country. CREDIT Argonne National Laboratory
BLACKSBURG, VA (WVNS) — A program at Virginia Tech empowers students with knowledge and skills to build or launch companies. According to a release, the Apex Center for Entrepreneurship is on track to engage more than 3,000 students across the college campus.
Apex Director Sean Collins shared that the center is building the 21st century workforce, and is helping entrepreneurs work in cross-functional teams, navigate ambiguity, assess risk, and build new technology fluency.
Image: https://www.wvnstv.com
A group of academic, biotech, biopharma, and healthcare leaders at Harvard and across Massachusetts plan to create a new center for innovation and manufacturing next-generation medicines, according to a Monday press release.
The center, which is estimated to cost $50 million dollars, will be an independent non-profit located in the Greater Boston area. The board of directors of the new center includes leaders from Harvard, MIT, Fujifilm Diosynth Biotechnologies, GE Healthcare Life Sciences, and Alexandria Real Estate Equities, Inc.
Image: Senior members of Harvard’s central administration, including University Provost Alan M. Garber ’76, work in Massachusetts Hall. Photo: Sydney R. Mason
From gene editing to microfluidics, the scope for innovation in the field of life sciences is vast and ever-expanding. Yet many researchers don’t know how to make the leap from academia to industry.
Concordia’s District 3 aims to do something about that.
The District 3 Innovation Centre is working with the City of Montreal to help the biosciences and life sciences industries address shortages of scientific talent, as well as to train graduates who seek jobs to match their skill set.
“I’m thrilled to be joining Deloitte and continue to follow my passion for understanding how data science methods and technologies can be applied to biomedical data to yield a better understanding of biology,” Bonazzi said. “I’m looking forward to supporting agencies in their mission to utilize data science to better understand and use complex biomedical data.”
Plans are moving forward for another Bay Area biotech campus. Alexandria Real Estate Equities is transforming a chunk of property in San Carlos into a 1.6 million-square-foot biotech campus.
According to the San Francisco Business Times, the real estate development company submitted plans for its proposed biotech campus. The site in question includes multiple office buildings, including the former corporate headquarters of Kelly-Moore Paints. Most of the buildings on the swath of property are decades old. Alexandria Real Estate Equities intends to turn the space into six new buildings, each about five to seven floors for biotech companies to use. In addition to the buildings, the site will also include an amenities structure, parking garages and a small park, according to the Business Times.
CAMBRIDGE, Mass. & GAITHERSBURG, Md.–(BUSINESS WIRE)–Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and MaxCyte, Inc., a global cell-based therapies and life sciences company, today announced a clinical and commercial license agreement under which Vor will use MaxCyte’s Flow Electroporation® technology to produce eHSCs and initiate Investigational New Drug (IND)-enabling studies to accelerate its progress towards the clinic.
ROCKVILLE, Md., Nov. 25, 2019 /PRNewswire/ — Emmes today announced that Lynn Lewis has joined the company as chief business officer, a newly created position. Her overall focus is to build deeper relationships with existing clients and to develop new business opportunities, particularly among biotech and pharmaceutical companies.
Lewis will be responsible for sales, marketing, communications, strategic planning and partnerships, and proposal development.
Dr. Anne Lindblad, president and chief executive officer of Emmes, said, “Lynn understands the importance of science in our business. She will extend our reputation and value as a trusted scientific partner with those who share our passion for designing and executing important studies aimed at improving human health.”
